MGMT and central nervous system cancer: We did not observe significant difference of SCG3 expression between gliomas grouped by other common genetic features in gliomas, such as TERT promoter mutations (Supplementary Figures S2A,B) and MGMT promoter methylation (Supplementary Figures S2C,D).